Literature DB >> 17362804

Comorbid alcohol and substance abuse dependence in depression: impact on the outcome of antidepressant treatment.

Michael J Ostacher1.   

Abstract

Major depressive disorder often co-occurs with substance use disorders, especially alcohol use disorders, and the course of each of these problems seems be complicated by the other. Diagnosing and treating these patients is challenging. A significant difficulty for clinicians is deciding whether to treat a mood episode in a patient who has current substance use or a substance use disorder, and what is the optimal treatment for that patient. This article discusses the prevalence of depressive and substance use disorder, the course of illness of comorbid depression and substance use disorders, and treatment response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17362804     DOI: 10.1016/j.psc.2006.12.009

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  21 in total

1.  Diagnosing and managing complicated ADHD.

Authors:  Robert L Findling; L Eugene Arnold; Laurence L Greenhill; Christopher J Kratochvil; James J McGough
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

2.  Meta-analysis of supplemental treatment for depressive and anxiety disorders in patients being treated for alcohol dependence.

Authors:  Jennifer D J Hobbs; Matt G Kushner; Susanne S Lee; Sean M Reardon; Eric W Maurer
Journal:  Am J Addict       Date:  2011-05-31

3.  Comparing treatment persistence, healthcare resource utilization, and costs in adult patients with major depressive disorder treated with escitalopram or citalopram.

Authors:  Eric Q Wu; Paul E Greenberg; Rym Ben-Hamadi; Andrew P Yu; Elaine H Yang; M Haim Erder
Journal:  Am Health Drug Benefits       Date:  2011-03

4.  Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial.

Authors:  Lori L Davis; Patricia Pilkinton; Stephen R Wisniewski; Madhukar H Trivedi; Bradley N Gaynes; Robert H Howland; Sidney Zisook; G K Balasubramani; Maurizio Fava; A John Rush
Journal:  Depress Anxiety       Date:  2012-02       Impact factor: 6.505

5.  Adjunctive aripiprazole therapy with escitalopram in patients with co-morbid major depressive disorder and alcohol dependence: clinical and neuroimaging evidence.

Authors:  Doug Hyun Han; Sun Mi Kim; Jung Eun Choi; Kyung Joon Min; Perry F Renshaw
Journal:  J Psychopharmacol       Date:  2013-01-16       Impact factor: 4.153

6.  Abstinence following alcohol drinking produces depression-like behavior and reduced hippocampal neurogenesis in mice.

Authors:  Jennie R Stevenson; Jason P Schroeder; Kimberly Nixon; Joyce Besheer; Fulton T Crews; Clyde W Hodge
Journal:  Neuropsychopharmacology       Date:  2008-06-18       Impact factor: 7.853

Review 7.  Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications.

Authors:  Jillan Cantor Sackett; Ronald A Weller; Elizabeth B Weller
Journal:  Curr Psychiatry Rep       Date:  2009-06       Impact factor: 5.285

8.  Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient population.

Authors:  Bradley N Gaynes; Brian Wells Pence; Joseph J Eron; William C Miller
Journal:  Psychosom Med       Date:  2008-03-31       Impact factor: 4.312

9.  Predictors of early and sustained cessation of heavy drinking over 5 years among adult primary care patients.

Authors:  Vanessa A Palzes; Andrea H Kline-Simon; Derek D Satre; Stacy Sterling; Constance Weisner; Felicia W Chi
Journal:  Addiction       Date:  2021-07-12       Impact factor: 6.526

Review 10.  Incomplete remission in depression: role of psychiatric and somatic comorbidity.

Authors:  Christian Otte
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.